Company profile · Biotech & medical
Medigen Biotechnology
基亞生物科技股份有限公司 · 3176
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Medigen Biotechnology engages in biopharmaceutical research and development, focusing on liver disease, cancer, and other major diseases.[1]
The company develops diverse fields including new drug research and development, molecular diagnostics, vaccine technology, and generic drugs.[2]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$152m | +6.6% | -40.6% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$43m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | Medigen Biotechnology Corporation |
|---|---|
| Chinese name | 基亞生物科技股份有限公司 |
| Stock code | 3176 (TPEx) |
| Industry | Biotech & medical |
| Founded | 31 Dec 1999 |
| Listed | 23 Nov 2011 |
| Paid-in capital | NT$1.4bn |
| Chairman | 張世忠 |
| President | 張世忠 |
| Headquarters | 14F.,Bldg.F,NO.3,Yuancyu ST.,Nangang District,Taipei City 115,Taiwan Taipei, Taiwan 115. |
| Website | https://www.medigen.com.tw |
| Official business description | 生物製藥研發業務 · 中 、西藥之批發、零售業 · 醫療器材、動物用藥之批發、零售業及國際貿易業 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- MOPS 公司基本資料 基亞生物科技股份有限公司 · mops · retrieved 04 Nov 2026
- 基亞生物科技股份有限公司 · website · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list